Activatable Photosensitizers: From Fundamental Principles to Advanced Designs
Angewandte Chemie International Edition · 07.04.2025 · 64 (15)
DOI: 10.1002/anie.202423348 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 21.02.2025. Verfasst von Nahyun Kwon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Princess Margaret Cancer Centre, University Health Network, 101 College Street, PMCRT 5-354, Toronto, ON, M5G1L7, Canada. Hauptthemen laut MEDLINE: Photosensitizing Agents, Drug Design. Die Arbeit wurde bisher 129-mal zitiert (Crossref) und nennt 277 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Terry Fox Research Institute, CIHR, Canada Excellence Research Chairs, Government of Canada.
Abstract (Originalsprache)
Photodynamic therapy (PDT) is a promising treatment that uses light to excite photosensitizers in target tissue, producing reactive oxygen species and localized cell death. It is recognized as a minimally invasive, clinically approved cancer therapy with additional preclinical applications in arthritis, atherosclerosis, and infection control. A hallmark of ideal PDT is delivering disease‐specific cytotoxicity while sparing healthy tissue. However, conventional photosensitizers often suffer from non‐specific photoactivation, causing off‐target toxicity. Activatable photosensitizers (aPS) have emerged as more precise alternatives, offering controlled activation. Unlike traditional photosensitizers, they remain inert and photoinactive during circulation and off‐target accumulation, minimizing collateral damage. These photosensitizers are designed to “turn on” in response to disease‐specific biostimuli, enhancing therapeutic selectivity and reducing off‐target effects. This review explores the principles of aPS, including quenching mechanisms stemming from activatable fluorescent probes and applied to activatable photosensitizers (RET, PeT, ICT, ACQ, AIE), as well as pathological biostimuli (pH, enzymes, redox conditions, cellular internalization), and bioresponsive constructs enabling quenching and activation. We also provide a critical assessment of unresolved challenges in aPS development, including limitations in targeting precision, selectivity under real‐world conditions, and potential solutions to persistent issues (dual‐lock, targeting moieties, biorthogonal chemistry and artificial receptors). Additionally, it provides an in‐depth discussion of essential research design considerations needed to develop translationally relevant aPS with improved therapeutic outcomes and specificity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Princess Margaret Cancer Centre, University Health Network, 101 College Street, PMCRT 5-354, Toronto, ON, M5G1L7, Canada.
- Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
- Department of Medicine, University of Toronto, Toronto, ON, Canada.
ORCID-Profile: Gang Zheng
Förderung
- Terry Fox Research Institute
- CIHR
- Canada Excellence Research Chairs, Government of Canada
- Princess Margaret Cancer Foundation
- Canadian Institutes of Health Research
Zitieren
APA
Kwon, N., Weng, H., Rajora, M. A., & Zheng, G. (2025). Activatable Photosensitizers: From Fundamental Principles to Advanced Designs. Angewandte Chemie International Edition, 64(15). https://doi.org/10.1002/anie.202423348
Vancouver
Kwon N, Weng H, Rajora MA, Zheng G. Activatable Photosensitizers: From Fundamental Principles to Advanced Designs. Angewandte Chemie International Edition. 2025;64(15). doi:10.1002/anie.202423348
BibTeX
@article{Kwon2025,
author = {Kwon, Nahyun and Weng, Hanyi and Rajora, Maneesha A and Zheng, Gang},
title = {Activatable Photosensitizers: From Fundamental Principles to Advanced Designs},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {15},
doi = {10.1002/anie.202423348}
}
EUVIMED